Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Fizazi, K; Shore, N; Tammela, TL; Ulys, A; Vjaters, E; Polyakov, S; Jievaltas, M; Luz, M; Alekseev, B; Kuss, I; Kappeler, C; Snapir, A; Sarapohja, T; Smith, MR

Fizazi, K (reprint author), Inst Gustave Roussy, Dept Canc Med, 114 Rue Edouard Vaillant, F-94800 Villejuif, France.

NEW ENGLAND JOURNAL OF MEDICINE, 2019; 380 (13): 1235

Abstract

BACKGROUND Darolutamide is a structurally unique androgen-receptor antagonist that is under development for the treatment of prostate cancer. We evalu......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索